Literature DB >> 22138752

Key contribution of CPEB4-mediated translational control to cancer progression.

Elena Ortiz-Zapater1, David Pineda, Neus Martínez-Bosch, Gonzalo Fernández-Miranda, Mar Iglesias, Francesc Alameda, Mireia Moreno, Carolina Eliscovich, Eduardo Eyras, Francisco X Real, Raúl Méndez, Pilar Navarro.   

Abstract

Malignant transformation, invasion and angiogenesis rely on the coordinated reprogramming of gene expression in the cells from which the tumor originated. Although deregulated gene expression has been extensively studied at genomic and epigenetic scales, the contribution of the regulation of mRNA-specific translation to this reprogramming is not well understood. Here we show that cytoplasmic polyadenylation element binding protein 4 (CPEB4), an RNA binding protein that mediates meiotic mRNA cytoplasmic polyadenylation and translation, is overexpressed in pancreatic ductal adenocarcinomas and glioblastomas, where it supports tumor growth, vascularization and invasion. We also show that, in pancreatic tumors, the pro-oncogenic functions of CPEB4 originate in the translational activation of mRNAs that are silenced in normal tissue, including the mRNA of tissue plasminogen activator, a key contributor to pancreatic ductal adenocarcinoma malignancy. Taken together, our results document a key role for post-transcriptional gene regulation in tumor development and describe a detailed mechanism for gene expression reprogramming underlying malignant tumor progression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22138752     DOI: 10.1038/nm.2540

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  58 in total

1.  The plasminogen activator system in pancreas cancer: role of t-PA in the invasive potential in vitro.

Authors:  R Paciucci; M Torà; V M Díaz; F X Real
Journal:  Oncogene       Date:  1998-02-05       Impact factor: 9.867

2.  Plasminogen activator dependent pathways in the dissemination of human tumor cells in the chick embryo.

Authors:  L Ossowski
Journal:  Cell       Date:  1988-02-12       Impact factor: 41.582

3.  Rapid, activity-induced increase in tissue plasminogen activator is mediated by metabotropic glutamate receptor-dependent mRNA translation.

Authors:  Chan Y Shin; Mitchell Kundel; David G Wells
Journal:  J Neurosci       Date:  2004-10-20       Impact factor: 6.167

4.  Galectin-1 is a novel functional receptor for tissue plasminogen activator in pancreatic cancer.

Authors:  Oriol Roda; Elena Ortiz-Zapater; Neus Martínez-Bosch; Ricardo Gutiérrez-Gallego; Miquel Vila-Perelló; Coral Ampurdanés; Hans-Joachim Gabius; Sabine André; David Andreu; Francisco X Real; Pilar Navarro
Journal:  Gastroenterology       Date:  2008-12-13       Impact factor: 22.682

5.  DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer.

Authors:  Christine A Iacobuzio-Donahue; Baojin Fu; Shinichi Yachida; Mingde Luo; Hisashi Abe; Clark M Henderson; Felip Vilardell; Zheng Wang; Jesse W Keller; Priya Banerjee; Joseph M Herman; John L Cameron; Charles J Yeo; Marc K Halushka; James R Eshleman; Marian Raben; Alison P Klein; Ralph H Hruban; Manuel Hidalgo; Daniel Laheru
Journal:  J Clin Oncol       Date:  2009-03-09       Impact factor: 44.544

Review 6.  CPEB: a life in translation.

Authors:  Joel D Richter
Journal:  Trends Biochem Sci       Date:  2007-05-04       Impact factor: 13.807

7.  Widespread shortening of 3'UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells.

Authors:  Christine Mayr; David P Bartel
Journal:  Cell       Date:  2009-08-21       Impact factor: 41.582

8.  Cross-species comparison of human and mouse intestinal polyps reveals conserved mechanisms in adenomatous polyposis coli (APC)-driven tumorigenesis.

Authors:  Claudia Gaspar; Joana Cardoso; Patrick Franken; Lia Molenaar; Hans Morreau; Gabriela Möslein; Julian Sampson; Judith M Boer; Renée X de Menezes; Riccardo Fodde
Journal:  Am J Pathol       Date:  2008-04-10       Impact factor: 4.307

Review 9.  The urokinase plasminogen activator system: a target for anti-cancer therapy.

Authors:  Salvatore Ulisse; Enke Baldini; Salvatore Sorrenti; Massimino D'Armiento
Journal:  Curr Cancer Drug Targets       Date:  2009-02       Impact factor: 3.428

10.  Increased microRNA activity in human cancers.

Authors:  Ariel Israel; Roded Sharan; Eytan Ruppin; Eithan Galun
Journal:  PLoS One       Date:  2009-06-25       Impact factor: 3.240

View more
  66 in total

1.  Identification of a conserved interface between PUF and CPEB proteins.

Authors:  Zachary T Campbell; Elena Menichelli; Kyle Friend; Joann Wu; Judith Kimble; James R Williamson; Marvin Wickens
Journal:  J Biol Chem       Date:  2012-04-11       Impact factor: 5.157

Review 2.  Translational control by changes in poly(A) tail length: recycling mRNAs.

Authors:  Laure Weill; Eulàlia Belloc; Felice-Alessio Bava; Raúl Méndez
Journal:  Nat Struct Mol Biol       Date:  2012-06-05       Impact factor: 15.369

Review 3.  Role of 3'-untranslated region translational control in cancer development, diagnostics and treatment.

Authors:  Andrii Vislovukh; Thaiz Rivera Vargas; Anna Polesskaya; Irina Groisman
Journal:  World J Biol Chem       Date:  2014-02-26

4.  Downregulated cytoplasmic polyadenylation element-binding protein-4 is associated with the carcinogenesis of head and neck squamous cell carcinoma.

Authors:  Manli Zeng; Fen Li; Lei Wang; Chen Chen; Xiaolin Huang; Xingyu Wu; Wensheng She; Lin Zhou; Zezhang Tao
Journal:  Oncol Lett       Date:  2017-12-20       Impact factor: 2.967

5.  Oncogenic Activation of the RNA Binding Protein NELFE and MYC Signaling in Hepatocellular Carcinoma.

Authors:  Hien Dang; Atsushi Takai; Marshonna Forgues; Yotsowat Pomyen; Haiwei Mou; Wen Xue; Debashish Ray; Kevin C H Ha; Quaid D Morris; Timothy R Hughes; Xin Wei Wang
Journal:  Cancer Cell       Date:  2017-07-10       Impact factor: 31.743

6.  Cooperativity in RNA-protein interactions: global analysis of RNA binding specificity.

Authors:  Zachary T Campbell; Devesh Bhimsaria; Cary T Valley; Jose A Rodriguez-Martinez; Elena Menichelli; James R Williamson; Aseem Z Ansari; Marvin Wickens
Journal:  Cell Rep       Date:  2012-05-31       Impact factor: 9.423

7.  High expression of cytoplasmic polyadenylation element-binding protein 4 correlates with poor prognosis of patients with colorectal cancer.

Authors:  Xiaosheng He; Xutao Lin; Muyan Cai; Dejun Fan; Xiuting Chen; Lei Wang; Xiaojian Wu; Ping Lan; Jianping Wang
Journal:  Virchows Arch       Date:  2016-10-22       Impact factor: 4.064

8.  Translational control of cell growth and malignancy by the CPEBs.

Authors:  Andrea D'Ambrogio; Kentaro Nagaoka; Joel D Richter
Journal:  Nat Rev Cancer       Date:  2013-02-28       Impact factor: 60.716

9.  AMPK and PFKFB3 mediate glycolysis and survival in response to mitophagy during mitotic arrest.

Authors:  Elena Doménech; Carolina Maestre; Lorena Esteban-Martínez; David Partida; Rosa Pascual; Gonzalo Fernández-Miranda; Esther Seco; Ramón Campos-Olivas; Manuel Pérez; Diego Megias; Katherine Allen; Miguel López; Asish K Saha; Guillermo Velasco; Eduardo Rial; Raúl Méndez; Patricia Boya; María Salazar-Roa; Marcos Malumbres
Journal:  Nat Cell Biol       Date:  2015-08-31       Impact factor: 28.824

10.  RNA recognition and self-association of CPEB4 is mediated by its tandem RRM domains.

Authors:  Constanze Schelhorn; James M B Gordon; Lidia Ruiz; Javier Alguacil; Enrique Pedroso; Maria J Macias
Journal:  Nucleic Acids Res       Date:  2014-07-31       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.